Inside one neurologist’s quest to solve the mystery of COVID’s most puzzling complication
https://www.chicagomag.com/chicago-magazine/october-2022/the-long-haul/
And plenty of people are developing it. Long COVID is now the country’s third leading neurological disorder, the American Academy of Neurology declared in July. As of the end of May, there were 82.5 million COVID survivors in the United States, and 30 percent of them — about 24.8 million — were considered “long-haulers.” A recent study of Northwestern’s Neuro COVID-19 Clinic patients showed that most neurological symptoms persist for an average of nearly 15 months after the disease’s onset.
Oops? Too bad neurology has denied this issue for decades.
So Koralnik and his neuro-COVID research team are taking an all-hands-on-deck approach to cracking the long-COVID code and developing treatments to alleviate the often incapacitating neurological symptoms. And they’re also scrambling to persuade others to care — including, crucially, those with the power to finance their research.
Koralnik finds it infuriating that critical funding has been slow in coming. “Where is the sense of urgency?” he asks. “If this is not enough to create urgency, what is?”
Well, it's not in neurology. Or in medicine. It's in the "activists" out there, and a few experienced researchers.
“Neurologists are not necessarily drawn to infectious diseases, and infectious disease physicians don’t practice neurology,” he says. “So I decided to specialize in the neurologic manifestation of HIV and, by extension, of infectious diseases.”
Oops again? It's not as if neuroimmune diseases are brand new, or anything like that. Echoes of "bacteria can't survive in the acidic environment of the stomach".
“We thought that we were going to see mostly patients who were hospitalized, who survived and now needed some ongoing care for neurology as an outpatient,” Koralnik says. “But what we saw is the opposite. The main population of the clinic is the people who were never hospitalized with COVID, who had only a mild sore throat, a cough that went away, or a bit of fever — and then [experienced] the lingering, persistent, and then debilitating brain fog, headaches, dizziness, muscle pain, trouble with smell and taste, blurry vision, tinnitus, and intense fatigue.”
We told you.
The consequences can be profound. “Cognition may be affected in a way that you can’t multitask the way you were multitasking before,” Koralnik says. “You can’t be, you know, a reporter because you can’t figure out all the different deadlines that you have. You can’t be a police officer or a nurse or a businessperson. So that affects people in their ability to keep their current job.” The Brookings Institution reported in August that between two million and four million Americans aren’t working because of the effects of long COVID. Says Nath: “Once you damage the brain, the societal consequences are enormous.”
We warned you about that, too. For decades. Literally.
Citing his 25-year track record of obtaining funding, he makes a point of saying: “I love NIH. I think it’s the greatest institution that supports research in the world.” That said, he is dismayed that the government agency overseeing public health has been much less responsive to the neurological issues associated with long COVID, a disease afflicting close to 25 million Americans. “Now I’m studying the most frequent disease in the world, which is COVID, and the third most frequent disease in the U.S. today, which is long COVID, and I have to spend even more time to convince people that, one, it’s real; two, it should be studied; and, three, it should be funded by NIH,” he says.
Same old story. Same old failure.
A request to interview RECOVER cochair Walter Koroshetz, the director of NIH’s National Institute of Neurological Disorders and Stroke, about Koralnik’s work was met with a response that he was unavailable. But the NIH’s Nath agrees with Koralnik about the need to study long COVID. “Chronic fatigue syndrome, Gulf War syndrome, post-Lyme syndrome, sick building syndrome — nobody knows what causes them, but if you look at them, they’re very similar complaints,” Nath says. “If you study long COVID and figure this one out, maybe we can benefit these other ones at the same time.”
Same old failure. Best they can do is letting crumbs fall onto us if they can't find excuses to hold them.